Bullous pemphigold treated with mycophenolate mofetil [4]

Lancet

Volumn 349, Issue 9051, 1997, Pages 541-

  Böhm, Markus ^a   Baissert, Stefan ^b   Schwarz, Thomas ^b   Metze, Dieter ^b   Luger, Thomas ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; DRUG DERIVATIVE; MYCOPHENOLIC ACID;

AGED; BASEMENT MEMBRANE; CASE REPORT; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LETTER; MALE; PEMPHIGOID; PRIORITY JOURNAL; SKIN BIOPSY; BULLOUS PEMPHIGOID; PATHOLOGY; TREATMENT OUTCOME;

AGED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; PEMPHIGOID, BULLOUS; TREATMENT OUTCOME;

EID: 0031583131     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)80092-X     Document Type: Article

References (3)

1. Lipsky J. Mycophenolate mofetil. Lancet 1996; 348: 1357-59.
2. Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic acid for psoriasis. J Am Acad Dermatol 1987; 17: 962-71.
3. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 1993; 11: S117-19.